US Stock MarketDetailed Quotes
BDR Blonder Tongue Laboratories
- 0.3050
- 0.00000.00%
Close Oct 11 09:30 ET
4.08MMarket Cap-1386P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.3050Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)13.37MShares0.314652wk High3.81P/B2.29MFloat Cap0.280052wk Low--Dividend TTM7.50MShs Float18.4375Historical High--Div YieldTTM0.00%Amplitude0.2500Historical Low--Avg Price1Lot Size
Blonder Tongue Laboratories Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -66.67%78K | 63.67%-1.17M | 49.20%-540K | -527.50%-753K | 90.90%-108K | 127.79%234K | 50.87%-3.21M | 30.75%-1.06M | 80.89%-120K | 12.14%-1.19M |
| Net income from continuing operations | -178.74%-1.15M | 101.12%84K | 61.58%-927K | 88.75%-201K | 236.18%1.63M | 80.10%-414K | -907.28%-7.47M | 37.19%-2.41M | -33.96%-1.79M | -34.01%-1.19M |
| Operating gains losses | -127.37%-52K | -4,158.97%-1.58M | --23K | ---80K | ---1.72M | --190K | 100.55%39K | ---- | ---- | ---- |
| Depreciation and amortization | -9.82%257K | 3.63%1.14M | 5.43%291K | 3.31%281K | 4.41%284K | 1.42%285K | -0.72%1.1M | -42.02%276K | 4.62%272K | 26.51%272K |
| Other non cash items | -19.78%73K | 141.61%331K | 78.05%73K | 69.77%73K | 147.37%94K | 506.67%91K | -63.85%137K | -84.76%41K | 326.32%43K | -58.24%38K |
| Change In working capital | 1,835.42%833K | -171.45%-1.67M | -115.36%-100K | -176.87%-964K | -40.15%-555K | -105.83%-48K | 381.76%2.33M | -49.77%651K | 285.85%1.25M | 57.60%-396K |
| -Change in receivables | -43.03%380K | -97.87%11K | 100.00%40K | -83.50%50K | -482.81%-746K | 107.79%667K | 194.86%516K | 108.58%20K | -64.10%303K | 89.59%-128K |
| -Change in inventory | -665.00%-113K | -117.89%-791K | -165.73%-773K | -115.50%-305K | -40.40%267K | -97.59%20K | 351.05%4.42M | 5,445.45%1.18M | 550.34%1.97M | 135.98%448K |
| -Change in prepaid assets | 69.39%-292K | -289.08%-554K | 31.18%732K | -504.71%-344K | 108.76%12K | -347.89%-954K | 845.16%293K | 350.00%558K | 280.85%85K | -159.57%-137K |
| -Change in payables and accrued expense | 162.26%1.09M | 119.82%462K | 113.26%127K | 82.12%-177K | 120.38%96K | 372.73%416K | -201.52%-2.33M | -153.19%-958K | -755.63%-990K | -132.91%-471K |
| -Change in other current assets | -933.33%-31K | -104.26%-8K | -161.70%-29K | -84.00%12K | -84.81%12K | 76.92%-3K | 118.82%188K | 124.35%47K | 388.46%75K | 3,850.00%79K |
| -Change in other current liabilities | -4.12%-202K | -4.38%-787K | -2.60%-197K | -6.95%-200K | -4.81%-196K | -3.19%-194K | -32.28%-754K | -6.08%-192K | -16.88%-187K | -53.28%-187K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -66.67%78K | 63.67%-1.17M | 49.20%-540K | -527.50%-753K | 90.90%-108K | 127.79%234K | 50.87%-3.21M | 30.75%-1.06M | 80.89%-120K | 12.14%-1.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 88.89%-4K | 54.97%-86K | 32.14%-19K | 69.23%-4K | 81.25%-27K | -500.00%-36K | -102.02%-191K | 37.78%-28K | 92.26%-13K | -114.93%-144K |
| Capital expenditure reported | ---- | 81.21%-31K | ---- | ---- | ---- | ---- | 37.26%-165K | ---- | ---- | ---- |
| Net PPE purchase and sale | ---2K | ---- | ---- | 50.00%-4K | 93.55%-8K | --0 | ---- | ---- | 94.59%-8K | -163.83%-124K |
| Net intangibles purchase and sale | 94.44%-2K | -111.54%-55K | --0 | --0 | ---19K | ---36K | 50.94%-26K | 91.67%-1K | 75.00%-5K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 88.89%-4K | 54.97%-86K | 32.14%-19K | 69.23%-4K | 81.25%-27K | -500.00%-36K | -102.02%-191K | 37.78%-28K | 92.26%-13K | -114.93%-144K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -12.80%-238K | -49.72%1.46M | -48.20%562K | 366.15%684K | -75.36%423K | -159.44%-211K | 199.21%2.9M | -39.15%1.09M | -126.97%-257K | 85,750.00%1.72M |
| Net issuance payments of debt | -10.70%-238K | -56.92%894K | 23.95%326K | 256.15%406K | -78.04%377K | -160.56%-215K | 170.82%2.08M | -86.21%263K | -131.36%-260K | 34,440.00%1.72M |
| Net common stock issuance | ---- | -39.41%492K | -71.06%235K | ---- | ---- | ---- | --812K | --812K | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | 453.85%72K | -90.00%1K | 600.00%21K | --46K | --4K | 85.71%13K | 108.06%10K | -97.58%3K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -12.80%-238K | -49.72%1.46M | -48.20%562K | 366.15%684K | -75.36%423K | -159.44%-211K | 199.21%2.9M | -39.15%1.09M | -126.97%-257K | 85,750.00%1.72M |
| Net cash flow | ||||||||||
| Beginning cash position | 297.10%274K | -87.94%69K | 261.33%271K | -26.02%344K | -29.11%56K | -87.94%69K | 2.33%572K | -79.67%75K | 119.34%465K | -95.15%79K |
| Current changes in cash | -1,161.54%-164K | 140.76%205K | 150.00%3K | 81.28%-73K | -25.39%288K | 97.36%-13K | -3,969.23%-503K | -102.96%-6K | -348.41%-390K | 127.26%386K |
| End cash Position | 96.43%110K | 297.10%274K | 297.10%274K | 261.33%271K | -26.02%344K | -29.11%56K | -87.94%69K | -87.94%69K | -79.67%75K | 119.34%465K |
| Free cash flow | -62.63%74K | 63.18%-1.25M | 48.76%-559K | -469.17%-757K | 89.86%-135K | 123.35%198K | 50.35%-3.4M | 32.02%-1.09M | 83.29%-133K | 6.14%-1.33M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg